1. Greene CE, Sykes JE, Moore GE, Goldstein RE, Schultz RD. Leptospirosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Saunders Elsevier; 2012:431-447.
  2. White AM, Zambrana-Torrelio C, Allen T, et. al. Hotspots of canine leptospirosis in the United States of America. Vet J. 2017;222:29-35.
  3. Stepanek A. Canine leptospirosis – on the rise? American Kennel Club Canine Health Foundation website. http://www.akcchf.org/educational-resources/library/articles/canine-leptospirosis-on-the.html. Published December 19, 2017. Accessed March 22, 2020.
  4. Sykes JE, Hartmann K, Lunn KF, Moore GE, Stoddard RA, Goldstein RE. 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med. 2011;25(1):1-13.
  5. Monahan AM, Callanan JJ, Nally JE. Review paper: host-pathogen interactions in the kidney during chronic leptospirosis. Vet Pathol. 2009;46(5):792-799.
  6. Harkin KR, Roshto YM, Sullivan JT, Purvis TJ, Chengappa MM. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. J Am Vet Med Assoc. 2003;222(9):1230-1233.
  7. Miotto BA, Guilloux AGA, Tozzi BF, et al. Prospective study of canine leptospirosis in shelter and stray dog populations: identification of chronic carriers and different Leptospira species infecting dogs. PLoS One. 2018;13(7):e0200384.
  8. LaFleur RL, Dant JC, Wasmoen TL. Prevention of disease and mortality in vaccinated dogs following experimental challenge with virulent leptospira. J Vet Intern Med. 2011;25(3):747.
  9. Nobivac® Lepto 4 [package insert]. Merck Animal Health; 2020; Madison, NJ.